Congenital neutropenia and cyclic neutropenia are disorders of neutrophil p
roduction predisposing patients to recurrent bacterial infections. Recently
the locus for autosomal dominant cyclic neutropenia was mapped to chromoso
me 19p13.3, and this disease is now attributable to mutations of the gene e
ncoding neutrophil elastase (the ELA2 gene). The authors hypothesized that
congenital neutropenia is also due to mutations of neutrophil elastase. Pat
ients with congenital neutropenia, cyclic neutropenia, or Shwachman-Diamond
syndrome were referred to the Severe Chronic Neutropenia International Reg
istry. Referring physicians provided hematologic and clinical data. Mutatio
nal analysis was performed by sequencing polymerase chain reaction (PCR)-am
plified genomic DNA for each of the 5 exons of the neutrophil ELA2 gene and
20 bases of the flanking regions. RNA from bone marrow mononuclear cells w
as; used to determine if the affected patients expressed both the normal an
d the abnormal transcript. Twenty-two of 25 patients with congenital neutro
penia had 18 different heterozygous mutations. Four of 4 patients with cycl
ic neutropenia and 0 of 3 patients with Shwachman-Diamond syndrome had muta
tions. For 5 patients with congenital neutropenia having mutations predicte
d to alter RNA splicing or transcript structure, reverse transcriptase-PCR
showed expression of both normal and abnormal transcripts. In cyclic neutro
penia, the mutations appeared to cluster near the active site of the molecu
le, whereas the opposite face was predominantly affected by the mutations f
ound in congenital neutropenia. This study indicates that mutations of the
gene encoding neutrophil elastase are probably the most common cause for se
vere congenital neutropenia as well as the cause for sporadic and autosomal
dominant cyclic neutropenia. (Blood. 2000;96:2317-2322) (C) 2000 by The Am
erican Society of Hematology.